Trademark: 88091437
Status Date
Monday, August 1, 2022
Filing Date
Friday, August 24, 2018
Published for Opposition
Tuesday, April 30, 2019
Abandoned Date
Monday, August 1, 2022
41 issuance and publication of books, journals and other communication media in print, electronic form or otherwise, namely, publishing and issuing of books, journals and scientific papers in the field of medicine and pharmaceuticals, especially for pharmaceutical companies, pharmacists, physicians, patients, health insurance companies and their professional associations
5 Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the treatment of inflammation and gout; vaccines; sanitary preparations for medical purposes; dietetic substances to support nutritional balance and/or to treat deficiencies, namely, vitamins, minerals and/or probiotic preparations adapted for medical use; Wound dressings; surgical dressings; bandages, adhesive patches and adhesive tapes for dressings; medical adhesives to bind wounds; bandages, adhesive patches, adhesive tapes and medical adhesives to close wounds, incisions and cuts
42 Scientific and technological services and research in the medical and pharmaceutical field, namely, pharmaceutical product development, product development of medical devices, development of healthcare software, development of healthcare informatics and scientific study and research services in the fields of medicine and the prevention, treatment and management of illnesses, diseases and disorders
AVERITAS PHARMACEUTICAL
"PHARMA"
Aug 1, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 1, 2022
Abandonment - No Use Statement Filed
May 17, 2022
Corrected Noa E-Mailed
May 16, 2022
Divisional Processing Complete
Mar 7, 2022
Divisional Request Received
Mar 7, 2022
Teas Request To Divide Received
Nov 30, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 29, 2021
Sou Extension 5 Granted
Nov 18, 2021
Sou Extension 5 Filed
Nov 18, 2021
Sou Teas Extension Received
Apr 30, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 28, 2021
Sou Extension 4 Granted
Apr 28, 2021
Sou Extension 4 Filed
Apr 28, 2021
Sou Teas Extension Received
Nov 18, 2020
Notice Of Approval Of Extension Request E-Mailed
Nov 16, 2020
Sou Extension 3 Granted
Nov 16, 2020
Sou Extension 3 Filed
Nov 16, 2020
Sou Teas Extension Received
May 29, 2020
Notice Of Approval Of Extension Request E-Mailed
May 27, 2020
Sou Extension 2 Granted
May 27, 2020
Sou Extension 2 Filed
May 27, 2020
Sou Teas Extension Received
Jan 15, 2020
Notice Of Approval Of Extension Request E-Mailed
Jan 15, 2020
Corrected Noa E-Mailed
Jan 14, 2020
Sou Extension 1 Granted
Dec 6, 2019
Sou Extension 1 Filed
Jan 14, 2020
Divisional Processing Complete
Dec 5, 2019
Divisional Request Received
Dec 20, 2019
Teas Response To Office Action Received
Dec 10, 2019
Itu Office Action Issued For Divisional Request
Dec 5, 2019
Teas Request To Divide Received
Dec 10, 2019
Case Assigned To Intent To Use Paralegal
Dec 6, 2019
Sou Teas Extension Received
Jun 25, 2019
Noa E-Mailed - Sou Required From Applicant
Apr 30, 2019
Official Gazette Publication Confirmation E-Mailed
Apr 30, 2019
Published For Opposition
Apr 10, 2019
Notification Of Notice Of Publication E-Mailed
Mar 22, 2019
Assigned To Lie
Feb 28, 2019
Approved For Pub - Principal Register
Feb 14, 2019
Teas/Email Correspondence Entered
Feb 13, 2019
Correspondence Received In Law Office
Feb 13, 2019
Teas Response To Office Action Received
Dec 13, 2018
Notification Of Priority Action E-Mailed
Dec 13, 2018
Priority Action E-Mailed
Dec 13, 2018
Priority Action Written
Dec 10, 2018
Assigned To Examiner
Sep 4, 2018
New Application Office Supplied Data Entered
Aug 28, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
